Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Mwinyi, J; Boström, A; Fehrer, I; Othman, A; Waeber, G; Marti-Soler, H; Vollenweider, P; Marques-Vidal, P; Schiöth, H B; von Eckardstein, A; Hornemann, T (2017). Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus. PLoS ONE, 12(5):e0175776.

Dohrn, M F; Othman, A; Hirshman, S K; Bode, H; Alecu, I; Fähndrich, E; Karges, W; Weis, J; Schulz, J B; Hornemann, T; Claeys, K G (2015). Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy? European Journal of Neurology, 22(5):806-814.

Othman, A; Rütti, M F; Ernst, D; Saely, C H; Rein, P; Drexel, H; Porretta-Serapiglia, C; Lauria, G; Bianchi, R; von Eckardstein, Arnold; Hornemann, T (2012). Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome? Diabetologia, 55(2):421-431.

Steiner, C; Othman, A; Saely, C H; Rein, P; Drexel, H; von Eckardstein, Arnold; Rentsch, K M (2011). Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus. PLoS ONE, 6(11):e25006.

Karuna, R; Park, R; Othman, A; Holleboom, A G; Motazacker, M M; Sutter, I; Kuivenhoven, J A; Rohrer, L; Matile, H; Hornemann, T; Stoffel, M; Rentsch, K M; von Eckardstein, Arnold (2011). Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Atherosclerosis, 219(2):855-863.

Bertea, M; Rütti, M F; Othman, A; Marti-Jaun, J; Hersberger, M; von Eckardstein, Arnold; Hornemann, T (2010). Deoxysphingoid bases as plasma markers in Diabetes mellitus. Lipids in Health and Disease, 9:84.

This list was generated on Sat Jul 21 04:14:41 2018 CEST.